JSM 2013 Home
Online Program Home
My Program

Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.

Activity Details


486 Wed, 8/7/2013, 8:30 AM - 10:20 AM CC-510c
Adaptive Designs: Challenges of Design and Analysis — Contributed Papers
Biopharmaceutical Section , Biometrics Section
Chair(s): Grace Liu, Jansen Research Development
8:35 AM Inference from Blinded Data in Randomized Clinical Trials Kefei Zhou, Amgen. Co ; Jeetu Ganju, Gilead
8:50 AM Interim Analysis for the Mean Difference of Two Samples Using Generalized P-Values Richard McNally, Covance
9:05 AM Sequential Monitoring of Covariate Adaptive Designs Hongjian Zhu, The University of Texas Health Science Center at Houston ; Feifang Hu, University of Virginia
9:20 AM Adaptive Blinded Bayesian Sample Size Re-Determination for Clinical Trials: Extensions and Risk Minimizations Andrew Hartley, PPD, Inc
9:35 AM Small-Scale Studies and Their Impact on Phase III Trials: Vanguards, Pilot Studies, and Run-Ins Sarah Baraniuk, UT-School of Public Health
9:50 AM Testing Key Secondary Claims in Adaptive Design Settings George Kordzakhia, Food & Drug Administration ; Eiji Ishida, FDA ; John Lawrence, FDA
10:05 AM Testing Multiple Endpoints in Group Sequential Designs Guohui Liu, Millennium: The Takeda Oncology Company ; Yi Liu, Millennium : The Takeda Oncology Company



2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.